Cargando…

Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV

Halophilic archaea is considered an promising natural source of many important metabolites. This study focused on one of the surface-active biomolecules named biosurfactants produced by haloarchaeon Natrialba sp. M6. The production trend was optimized and the product was partially purified and ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Hegazy, Ghada E., Abu-Serie, Marwa M., Abou-elela, G. M., Ghozlan, Hanan, Sabry, Soraya A., Soliman, Nadia A., Teleb, Mohamed, Abdel-Fattah, Yasser R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531635/
https://www.ncbi.nlm.nih.gov/pubmed/36195643
http://dx.doi.org/10.1038/s41598-022-20091-0
_version_ 1784801941236219904
author Hegazy, Ghada E.
Abu-Serie, Marwa M.
Abou-elela, G. M.
Ghozlan, Hanan
Sabry, Soraya A.
Soliman, Nadia A.
Teleb, Mohamed
Abdel-Fattah, Yasser R.
author_facet Hegazy, Ghada E.
Abu-Serie, Marwa M.
Abou-elela, G. M.
Ghozlan, Hanan
Sabry, Soraya A.
Soliman, Nadia A.
Teleb, Mohamed
Abdel-Fattah, Yasser R.
author_sort Hegazy, Ghada E.
collection PubMed
description Halophilic archaea is considered an promising natural source of many important metabolites. This study focused on one of the surface-active biomolecules named biosurfactants produced by haloarchaeon Natrialba sp. M6. The production trend was optimized and the product was partially purified and identified using GC–Mass spectrometry. Sequential optimization approaches, Plackett–Burman (PB) and Box–Behnken Designs (BBD) were applied to maximize the biosurfactants production from M6 strain by using 14 factors; pH, NaCl, agitation and glycerol; the most significant factors that influenced the biosurfactant production were used for Response Surface Methodology (RSM). The final optimal production conditions were agitation (150 rpm), glycerol (3%), NaCl (20.8%), pH (12) and cultivation temperature (37°C). GC–Mass spectrometry for the recovered extract revealed the presence of a diverse group of bipolar nature, hydrophobic hydrocarbon chain and charged function group. The majority of these compounds are fatty acids. Based on results of GC–MS, compositional analysis content and Zetasizer, it was proposed that the extracted biosurfactant produced by haloarchaeon Natrialba sp. M6 could be a cationic lipoprotein. The antiviral activity of such biosurfactant was investigated against hepatitis C (HCV) and herpes simplex (HSV1) viruses at its maximum safe doses (20 μg/mL and 8 μg/mL, respectively). Its mode of antiviral action was declared to be primarily via deactivating viral envelopes thus preventing viral entry. Moreover, this biosurfactant inhibited RNA polymerase- and DNA polymerase-mediated viral replication at IC(50) of 2.28 and 4.39 μg/mL, respectively also. Molecular docking studies showed that surfactin resided well and was bound to the specified motif with low and accepted binding energies (ΔG = − 5.629, − 6.997 kcal/mol) respectively. Therefore, such biosurfactant could be presented as a natural safe and effective novel antiviral agent.
format Online
Article
Text
id pubmed-9531635
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-95316352022-10-05 Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV Hegazy, Ghada E. Abu-Serie, Marwa M. Abou-elela, G. M. Ghozlan, Hanan Sabry, Soraya A. Soliman, Nadia A. Teleb, Mohamed Abdel-Fattah, Yasser R. Sci Rep Article Halophilic archaea is considered an promising natural source of many important metabolites. This study focused on one of the surface-active biomolecules named biosurfactants produced by haloarchaeon Natrialba sp. M6. The production trend was optimized and the product was partially purified and identified using GC–Mass spectrometry. Sequential optimization approaches, Plackett–Burman (PB) and Box–Behnken Designs (BBD) were applied to maximize the biosurfactants production from M6 strain by using 14 factors; pH, NaCl, agitation and glycerol; the most significant factors that influenced the biosurfactant production were used for Response Surface Methodology (RSM). The final optimal production conditions were agitation (150 rpm), glycerol (3%), NaCl (20.8%), pH (12) and cultivation temperature (37°C). GC–Mass spectrometry for the recovered extract revealed the presence of a diverse group of bipolar nature, hydrophobic hydrocarbon chain and charged function group. The majority of these compounds are fatty acids. Based on results of GC–MS, compositional analysis content and Zetasizer, it was proposed that the extracted biosurfactant produced by haloarchaeon Natrialba sp. M6 could be a cationic lipoprotein. The antiviral activity of such biosurfactant was investigated against hepatitis C (HCV) and herpes simplex (HSV1) viruses at its maximum safe doses (20 μg/mL and 8 μg/mL, respectively). Its mode of antiviral action was declared to be primarily via deactivating viral envelopes thus preventing viral entry. Moreover, this biosurfactant inhibited RNA polymerase- and DNA polymerase-mediated viral replication at IC(50) of 2.28 and 4.39 μg/mL, respectively also. Molecular docking studies showed that surfactin resided well and was bound to the specified motif with low and accepted binding energies (ΔG = − 5.629, − 6.997 kcal/mol) respectively. Therefore, such biosurfactant could be presented as a natural safe and effective novel antiviral agent. Nature Publishing Group UK 2022-10-04 /pmc/articles/PMC9531635/ /pubmed/36195643 http://dx.doi.org/10.1038/s41598-022-20091-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Hegazy, Ghada E.
Abu-Serie, Marwa M.
Abou-elela, G. M.
Ghozlan, Hanan
Sabry, Soraya A.
Soliman, Nadia A.
Teleb, Mohamed
Abdel-Fattah, Yasser R.
Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV
title Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV
title_full Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV
title_fullStr Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV
title_full_unstemmed Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV
title_short Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV
title_sort bioprocess development for biosurfactant production by natrialba sp. m6 with effective direct virucidal and anti-replicative potential against hcv and hsv
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531635/
https://www.ncbi.nlm.nih.gov/pubmed/36195643
http://dx.doi.org/10.1038/s41598-022-20091-0
work_keys_str_mv AT hegazyghadae bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv
AT abuseriemarwam bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv
AT abouelelagm bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv
AT ghozlanhanan bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv
AT sabrysorayaa bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv
AT solimannadiaa bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv
AT telebmohamed bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv
AT abdelfattahyasserr bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv